Scarica l'app Stockscreener
6.91
0.58%
-0.04
Dopo l'orario di chiusura:
6.94
0.03
+0.43%
Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie
Why Entrada Therapeutics Inc. stock is favored by pension fundsMarket Growth Review & AI Driven Price Forecasts - newser.com
How risky is Entrada Therapeutics Inc. stock nowGDP Growth & Reliable Momentum Entry Alerts - newser.com
Can Entrada Therapeutics Inc. stock resist market sell offsMarket Growth Summary & Precise Swing Trade Alerts - newser.com
Analyzing Entrada Therapeutics Inc. with multi timeframe charts2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Entrada Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Published on: 2025-11-06 22:32:58 - newser.com
Entrada Therapeutics price target lowered to $13 from $17 at Roth Capital - TipRanks
Promising Outlook for Entrada Therapeutics: Strategic Advancements in DMD and DM1 with Novel EEV Platform - TipRanks
Entrada Therapeutics Faces Losses But Keeps Wall Street’s Support - Finimize
Promising Advancements and Strategic Positioning Drive Buy Rating for Entrada Therapeutics Inc. - TipRanks
Entrada Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Entrada Therapeutics may issue up to $400 million in securitiesSEC filing - MarketScreener
Entrada Therapeutics earnings missed by $0.07, revenue fell short of estimates - Investing.com Canada
Entrada Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Entrada Therapeutics Q3 net loss widens to $44.1 mln - MarketScreener
Entrada Therapeutics Reports Third Quarter 2025 Financial Results - The Manila Times
Entrada Therapeutics (NASDAQ: TRDA) extends runway into 2027, ends quarter with $326.8M - Stock Titan
Is Entrada Therapeutics Inc. forming a bottoming baseInflation Watch & Real-Time Buy Signal Alerts - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.Portfolio Gains Report & Stock Timing and Entry Methods - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peers2025 Dividend Review & Daily Chart Pattern Signal Reports - newser.com
Will Entrada Therapeutics Inc. stock gain from strong economyWeekly Trend Report & Risk Adjusted Swing Trade Ideas - newser.com
Applying big data sentiment scoring on Entrada Therapeutics Inc.Trade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-05 12:10:19 - newser.com
Real time pattern detection on Entrada Therapeutics Inc. stockQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Published on: 2025-11-04 23:42:29 - newser.com
Visualizing Entrada Therapeutics Inc. stock with heatmapsWeekly Profit Recap & Accurate Intraday Trade Tips - newser.com
Understanding Entrada Therapeutics Inc.’s price movementJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Entrada Therapeutics, Inc. (TRDA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Entrada Therapeutics, Inc. (TRDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Published on: 2025-11-03 06:13:01 - newser.com
Entrada Therapeutics, Inc. (TRDA) stock forecast and price target - Yahoo! Finance UK
Applying sector rotation models to Entrada Therapeutics Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Entrada Therapeutics Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):